NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹323 Cr | ₹463 Cr | ₹272 Cr | ₹143 Cr | ₹147 Cr |
What is the latest Operating Profit of NEULAND LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹323 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹272 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹147 Cr |
How is Operating Profit of NEULAND LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹323 Cr | -30.12 | |
| Mar2024 | ₹463 Cr | 70.17 | |
| Mar2023 | ₹272 Cr | 90.61 | |
| Mar2022 | ₹143 Cr | -2.86 | |
| Mar2021 | ₹147 Cr | - | |
Compare Operating Profit of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹19,112.3 Cr | -0.4% | 21.7% | 20.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -0.4% |
21.7% |
20.2% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses